Nancy Beryl Janet

Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy

Ezhilarasi Chendamarai, Poonkuzhali Balasubramanian, Biju George et al. · Blood · 2012 · 57 citations · Full text

Medicine, Hematology, Oncology +15

Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance

Ezhilarasi Chendamarai, Saravanan Ganesan, Ansu Abu Alex et al. · PLoS ONE · 2015 · 52 citations · Full text

Medicine, Hematology, Oncology +14

RNA Expression of Genes Involved in Cytarabine Metabolism and Transport Predicts Cytarabine Response in Acute Myeloid Leukemia

Ajay Abraham, Savitha Varatharajan, Sreeja Karathedath et al. · Pharmacogenomics · 2015 · 45 citations · Full text

Medicine, Oncology, Pharmacology +14

Frequency of rare <i><scp>BCR</scp>‐<scp>ABL</scp>1</i> fusion transcripts in chronic myeloid leukemia patients

A. Senthamizhselvi, Sathya Mani, K. Vinodhini et al. · International Journal of Laboratory Hematology · 2016 · 37 citations

Life Sciences, Genetics, Hematology +14

A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide

Uday Kulkarni, Saravanan Ganesan, Ansu Abu Alex et al. · Cancer Medicine · 2020 · 26 citations · Full text

Medicine, Hematology, Pharmacology +16